← FDA DEVICE PRODUCT CODES

FDA PRODUCT CODE · CLASS II

PCHGastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System

A gastrointestinal pathogen panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal microbial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings.

DEVICE CLASS
Class II
REGULATION
21 CFR 866.3990
MEDICAL SPECIALTY
Microbiology
REVIEW PANEL
MI
ImplantLife-sustainingGMP-exemptThird-party review eligible
11
510(K)/PMA CLEARANCES
510k: 11
0
RECALL ENTRIES

Recent clearances

K253722Luminex Corporation · 510k2026-05-19
K254032QIAGEN GmbH · 510k2026-03-09
K251721Cepheid · 510k2026-01-16
K252329QIAGEN GmbH · 510k2025-10-22
K251993Hologic, Inc. · 510k2025-09-25
K251868Hologic · 510k2025-09-25
K250324QIAGEN GmbH · 510k2025-02-28
K243885Biofire Diagnostics, LLC · 510k2025-01-16

Related on SPEQ

Medical devices industryMedical device quality (ISO 13485)FDA device clearancesFDA enforcement & recalls

Source: FDA device classification, 510(k)/PMA, and recall datasets (openFDA). Recall entries count distinct FDA recall numbers, so one recall event affecting several products appears as several entries. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →